Studies have shown that the activation of NOX2 enzyme remarkably promoted cell death in central nervous system diseases (Sorce and Krause, 2009; Hur et al., 2010; Nayernia et al., 2014; Marrali et al., 2016). This evidence concerns the gene CYBB and central nervous system disorder.